drugset / Trial / NCT01908140
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)
Timeline
- Start
- 2013-09
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aclidinium | Small molecule | 400 ug | — |
| Comparator | Fluticasone propionate | Other / unclassified | 500 ug | — |
| Subject | Formoterol | Other / unclassified | 12 ug | — |
| Comparator | Salmeterol | Other / unclassified | 50 ug | — |